Smoking and quitting–a follow-up
Controlled substances: Who's watching the controllers?

More on CBD

This HND piece is a follow-up to previous postings on this exciting Cannabis extract. Cannabidiol is rapidly growing in popularity because it provides virtually all the medical benefits of Cannabis, without the psychotropic effects. As such, it should be of no interest to the DEA, but may eventually come under the FDA.

Thus, CBD suppliers are encouraged to act as if they already were regulated. Note how the FDA is starting to go hog-wild on e-cigarettes if any further convincing is needed. The piece provides many useful links—especially to research studies on how CBD can benefit sufferers of 46 medical conditions.

Read the complete article.


Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name is required. Email address will not be displayed with the comment.)